Synthesis of New 1-[4-Methane(amino)sulfonylphenyl)]-5-[4-(aminophenyl)]-3-trifluoromethyl-1H-pyrazoles

被引:11
作者
Abdellatif, Khaled R. A. [1 ]
Chowdhury, Morshed A. [1 ]
Knaus, Edward E. [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1002/jhet.5570450623
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A regiospecific cyclization-dehydration reaction of a 1-[4-(N-alkyl-N-(tert-butyloxycarbonyl)amino)phenyl]-4,4,4-trifluorobutane-1,3 -done with a 4-aminosulfonyl-, or 4-methylsulfonyl-, phenylhydrazine hydrochloride in refluxing ethanol proceeded with simultaneous loss of the N-tert-butyloxycarbonyl protecting group to afford a group of 1-(4-methanesulfonylphenyl or 4-aminosulfonylphenyl)-5-[4-(N-alkylaminophenyl)]-3-(trifluoromethyl)-1H-pyrazoles (6). Subsequent reaction of the pyrazole 6 (R-1 = R-2 = Me) with nitric oxide (40 psi) proceeded via a N-methylamino-N-diazen-1-ium-1,2-diolate intermediate that undergoes protonation of the more basic diazen-1-ium-1,2-diolate N-2-nitrogen and then loss of a nitroxyl (HNO) species to furnish the N-nitroso product 7.
引用
收藏
页码:1707 / 1710
页数:4
相关论文
共 13 条
  • [1] THE PHYSIOLOGICAL-ROLE OF NITRIC-OXIDE
    BUTLER, AR
    WILLIAMS, DLH
    [J]. CHEMICAL SOCIETY REVIEWS, 1993, 22 (04) : 233 - 241
  • [2] Adverse cardiovascular effects of the coxibs
    Dogné, JM
    Supuran, CT
    Pratico, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) : 2251 - 2257
  • [3] *KATIONEN-KATALYSIERTE REAKTIONEN VON CARBONSAUREAMIDEN
    KLAMANN, D
    [J]. MONATSHEFTE FUR CHEMIE, 1953, 84 (05): : 925 - 930
  • [4] 5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido-[2,3-d]pyrimidin-4-ylamine:: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors
    Matulenko, MA
    Lee, CH
    Jiang, M
    Frey, RR
    Cowart, MD
    Bayburt, EK
    DiDomenico, S
    Gfesser, GA
    Gomtsyan, A
    Zheng, GZ
    McKie, JA
    Stewart, AO
    Yu, HX
    Kohlhaas, KL
    Alexander, KM
    McGaraughty, S
    Wismer, CT
    Mikusa, J
    Marsh, KC
    Snyder, RD
    Diehl, MS
    Kowaluk, EA
    Jarvis, MF
    Bhagwat, SS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (11) : 3705 - 3720
  • [5] Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)
    Penning, TD
    Talley, JJ
    Bertenshaw, SR
    Carter, JS
    Collins, PW
    Docter, S
    Graneto, MJ
    Lee, LF
    Malecha, JW
    Miyashiro, JM
    Rogers, RS
    Rogier, DJ
    Yu, SS
    Anderson, GD
    Burton, EG
    Cogburn, JN
    Gregory, SA
    Koboldt, CM
    Perkins, WE
    Seibert, K
    Veenhuizen, AW
    Zhang, YY
    Isakson, PC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) : 1347 - 1365
  • [6] New COX-2/5-LOX inhibitors:: Apoptosis-inducing agents potentially useful in prostate cancer chemotherapy
    Pommery, N
    Taverne, T
    Telliez, A
    Goossens, L
    Charlier, C
    Pommery, J
    Goossens, JF
    Houssin, R
    Durant, F
    Hénichart, JP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) : 6195 - 6206
  • [7] The discovery of rofecoxib, [MK 966, Vioxx®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor
    Prasit, P
    Wang, Z
    Brideau, C
    Chan, CC
    Charleson, S
    Cromlish, W
    Ethier, D
    Evans, JF
    Ford-Hutchinson, AW
    Gauthier, JY
    Gordon, R
    Guay, J
    Gresser, M
    Kargman, S
    Kennedy, B
    Leblanc, Y
    Léger, S
    Mancini, J
    O'Neill, GP
    Ouellet, M
    Percival, MD
    Perrier, H
    Riendeau, D
    Rodger, I
    Tagari, P
    Thérien, M
    Vickers, P
    Wong, E
    Xu, LJ
    Young, RN
    Zamboni, R
    Boyce, S
    Rupniak, N
    Forrest, N
    Visco, D
    Patrick, D
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) : 1773 - 1778
  • [8] PREPARATION AND ANTI-DIABETIC ACTIVITY OF SOME SULFONYLUREA DERIVATIVES OF 3,5-DISUBSTITUTED PYRAZOLES
    SOLIMAN, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (03) : 321 - 325
  • [9] 4-[5-methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
    Talley, JJ
    Brown, DL
    Carter, JS
    Graneto, MJ
    Koboldt, CM
    Masferrer, JL
    Perkins, WE
    Rogers, RS
    Shaffer, AF
    Zhang, YY
    Zweifel, BS
    Seibert, K
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (05) : 775 - 777
  • [10] TOSCANO JP, 2005, Patent No. 2005074598